The Effect of Guilingji Capsules on Vascular Mild Cognitive Impairment: A Randomized, Double-Blind, Controlled Trial

Table 3

Comparison of MoCA, MMSE, and ADAS-Cog scores after treatment in the two groups.

		GLJC group (n = 37)	Ginkgo group (n = 45)	value
MoCA	Before treatment	20 (2.43)	20.47 (2.90)	0.438
	12-week treatment	23 (22–24)	22 (21–24)	0.180
	24-week treatment	25 (23.5–26)	23 (22.5–24)	≤0.001
MMSE	Before treatment	24 (24-25)	24 (24-25)	0.578
	12-week treatment	26 (25–28)	26 (25–27)	0.663
	24-week treatment	28 (27–29)	27 (25–28)	0.044
ADAS-Cog	Before treatment	21.54 (7.3)	20.63 (9.08)	0.624
	12-week treatment	15.82 (7.81)	15.76 (8.28)	0.972
	24-week treatment	12.02 (5.98)	14.02 (7.59)	0.185

Note: significant effect (). Normally distributed data are expressed as mean (SD), whereas nonnormally distributed data are expressed as median (IQR).